Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Syntactx | NETWORK |
Not provided
Not provided
The aim of the study is to evaluate the performance of Withings WBS08 with embedded Withings ECG Monitor in the automatic detection of atrial fibrillation
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Atrial fibrillation | Experimental |
| |
| Normal Sinus Rhythm | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Electrocardiogram recording | Device | ECG recording with investigational device |
|
| Measure | Description | Time Frame |
|---|---|---|
| Co-primary outcomes | Sensitivity (percentage of true positives) in detecting AF from conclusive recordings generated by the software under test, that is recordings resulting in a classification of AF or SR by the SUT, compared to the reference 12-lead ECG. | 4 months |
| Co-primary outcomes | Specificity (percentage of true negatives) in detecting AF from conclusive recordings generated by the software under test, that is recordings resulting in a classification of AF or SR by the SUT, compared to the reference 12-lead ECG. | 4 months |
| Measure | Description | Time Frame |
|---|---|---|
| Evaluation of the classification into heart rate subgroups | The classification into heart rate subgroups will be evaluated for the pairs of strips such that the rhythm classification of the 12-lead ECG is either SR or AF and such that the strip generated by the SUT is classified as either SR or AF. The evaluation will be assessed with the concordance of classifications, i.e. the percentage P of identical classifications by the SUT and the reference method, into each of the four following subgroups:
|
Not provided
Inclusion Criteria:
Exclusion Criteria:
Vulnerable subject with regard to regulations in force
Subject who refused to participate in the study,
Subject mentally impaired resulting in limited ability to cooperate
Subject with electrical stimulation by pacemaker
Patient with pathologic disorder that may affect motricity resulting in significant tremor that prevents subject from being able to hold still (e.g Parkinson disease)
Patient unable to stay in an upright position for the duration of study measures
Acute myocardial infarction (MI) within 90 days of screening or other cardiovascular disease that, in the opinion of the Investigator, may increase the risk to the subject or renders data uninterpretable (e.g., recent or ongoing unstable angina, decompensated heart failure, active myocarditis or pericarditis)
Acute pulmonary embolism or pulmonary infarction, within 90 days of screening
Stroke or transient ischemic attack within 90 days of screening
Active life-threatening rhythms as determined by the investigator (ventricular tachycardia, ventricular fibrillation, 3 rd -degree heart block).
History of life-threatening rhythms as determined by the investigator (ventricular tachycardia, ventricular fibrillation, 3 rd -degree heart block)
Symptomatic (or active) allergic skin reactions such as eczema, rosacea, impetigo, dermatomyositis or allergic contact dermatitis over electrode attachment sites
Known sensitivity to medical adhesives, isopropyl alcohol, or electrocardiogram (ECG) electrodes including known allergy or sensitivity to fluoroelastomer bands
Weight more than 180 kg
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jeffrey Wessler, MD | Heartbeat Health | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| FWD Clinical Research | Boca Raton | Florida | 33486 | United States | ||
| Florida Cardiovascular Research |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001281 | Atrial Fibrillation |
| ID | Term |
|---|---|
| D001145 | Arrhythmias, Cardiac |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D010335 | Pathologic Processes |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Electrocardiogram recording | Device | ECG recording with reference device |
|
| 4 months |
| Clinical Equivalence of ECG waveforms | Clinical Equivalence of ECG waveforms will be qualitatively and quantitatively assessed between the 6-leads generated by the SUT and the leads I, II, III, aVR, aVL, aVF of the 12-lead ECG by a board of certified cardiologists: The visibility and polarity of the P waves, QRS complexes and T waves will be determined by cardiologists and according to a set of predetermined rules. For each type of wave (P, QRS and T), | 4 months |
| Clinical Equivalence of ECG waveforms | The durations of the QT intervals, QRS complex widths, and PR intervals will be measured by cardiologists with a caliper and according to a set of predetermined rules for each of the 6 leads of the strips generated by the SUT and the leads I, II, III, aVR, aVL, aVF of the 12-lead ECG. | 4 months |
| Heart Rate equivalence | heart rate will be determined by independent cardiologists, or cardiac technicians supervised by cardiologists, from each six-channel strip recorded with the SUT and from each lead I, II, III, aVR, aVL, aVF of the 12-lead reference ECG | 4 months |
| Hialeah |
| Florida |
| 33012 |
| United States |
| Diverse Clinical Research | Miami | Florida | 33175 | United States |
| The Angel Medical Research | Miami Lakes | Florida | 33016 | United States |
| American Institute of Therapeutics | Lake Bluff | Illinois | 60044 | United States |
| Cambridge Medical Trials | Alexandria | Louisiana | 71301 | United States |
| Heartbeat Health | New York | New York | 10019 | United States |
| Texas Heart Institute | Houston | Texas | 77030 | United States |
| LINQ Research LLC | Pearland | Texas | 77584 | United States |
| Henri-Mondor Hospital | Créteil | Île-de-France Region | 94000 | France |
| D013568 |
| Pathological Conditions, Signs and Symptoms |